SI
MRNA icon

Stephens Inc’s Moderna MRNA Stock Holding History

Stephens Inc’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,334
Closed -$223K – 1324
2024
Q3 		$223K Buy
3,334
+245
+8% +$22.5K ﹤0.01% 1155
2024
Q2 		$367K Sell
3,089
-394
-11% -$49.9K 0.01% 924
2024
Q1 		$371K Buy
3,483
+155
+5% +$15.6K 0.01% 932
2023
Q4 		$331K Sell
3,328
-208
-6% -$17.5K 0.01% 899
2023
Q3 		$365K Sell
3,536
-20
-0.6% -$2.23K 0.01% 837
2023
Q2 		$432K Sell
3,556
-100
-3% -$13.3K 0.01% 789
2023
Q1 		$561K Buy
3,656
+40
+1% +$6.6K 0.01% 683
2022
Q4 		$650K Buy
3,616
+290
+9% +$47.4K 0.01% 615
2022
Q3 		$393K Buy
3,326
+98
+3% +$14.9K 0.01% 792
2022
Q2 		$461K Buy
3,228
+114
+4% +$16.3K 0.01% 747
2022
Q1 		$536K Buy
3,114
+193
+7% +$32.5K 0.01% 776
2021
Q4 		$742K Buy
2,921
+250
+9% +$73.1K 0.01% 730
2021
Q3 		$1.03M Sell
2,671
-70
-3% -$25.8K 0.02% 644
2021
Q2 		$644K Sell
2,741
-50
-2% -$8.94K 0.01% 797
2021
Q1 		$365K Sell
2,791
-600
-18% -$86.9K 0.01% 937
2020
Q4 		$354K Buy
+3,391
New +$343K 0.01% 876

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Stephens Inc's MRNA Position: Q4 2024 in Review

Stephens Inc sold out of Moderna (MRNA) in Q4 2024, closing a stake of 3,334 shares — an estimated $223K sold.

Stephens Inc first reported a position in MRNA in Q4 2020 and held it in 16 quarters. The position peaked at $1.03M in Q3 2021. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • Stephens Inc reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • Stephens Inc sold 3,334 Moderna shares in Q4 2024, an estimated $223K.
  • Stephens Inc first reported a position in Moderna in Q4 2020 and held it in 16 quarters.
  • Stephens Inc's Moderna position peaked at $1.03M in Q3 2021.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Stephens Inc's 13F filing for Q4 2024, filed 28 Jan 2025.